Clinical Trials Logo

Filter by:
NCT ID: NCT06166667 Recruiting - Clinical trials for Renal Insufficiency, Chronic

Effect of Fecal Capsule on Chronic Kidney Disease (CKD)

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

By collecting blood, urine and stool samples before and after oral Enterobacteriaceae capsule (FMT) from CKD subjects, we investigated the role and related mechanisms of gut microecology in the development of CKD using a combination of metagenomic sequencing, metabolomic analysis and flow cytometry.

NCT ID: NCT06166641 Recruiting - Pressure Ulcer Clinical Trials

Prediction Models for Risk Score and Prognosis of Intraoperatively Acquired Pressure Injury in Surgical Patients

Start date: August 1, 2023
Phase:
Study type: Observational

The study aims to effectively identify the risk of intraoperative acquired pressure injuries (IAPI) in surgical patients through a prospective multicenter approach. It combines indicators from commonly used assessment tools and practical experience judgments to construct a comprehensive assessment framework. By incorporating various indicators, the study aims to improve the accuracy and reliability of identifying patients at risk of IAPI during surgery. This will help clinicians in making informed decisions and implementing preventive measures to minimize the occurrence of pressure injuries. The multicenter approach ensures a diverse and representative sample of patients from different surgical settings. This increases the generalizability of the study findings and enhances the applicability of the assessment framework across various clinical settings. The project's methodology involves collecting data on patient demographics, medical history, surgical procedure details, and assessment tool scores. These data points will be analyzed to identify significant risk factors for IAPI and develop a risk prediction model. The study also takes into consideration practical experience judgments, which acknowledge the importance of clinical expertise in assessing patients' risk of IAPI. This ensures that the assessment framework is not solely reliant on assessment tools but also incorporates the insights of experienced clinicians. Overall, this prospective multicenter study aims to contribute to the field by providing a comprehensive and practical approach to identify the risk of IAPI in surgical patients. The findings from this study can be utilized in clinical practice to improve patient outcomes and reduce the incidence of pressure injuries during surgery.

NCT ID: NCT06166121 Recruiting - Hyperlipidemia Clinical Trials

Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules

Start date: September 20, 2023
Phase: N/A
Study type: Interventional

This study focuses on PWV as the main outcome, aiming to evaluate the efficacy and safety of ShenJu in treating patients with hyperlipidemia combined with carotid atherosclerosis, and provide a basis for traditional Chinese medicine treatment of hyperlipidemia combined with carotid atherosclerosis.

NCT ID: NCT06166082 Recruiting - Clinical trials for Treatment Resistant Depression

Stanford Neuromodulation Therapy (SNT) for the Treatment-Resistant Depression

Start date: December 22, 2023
Phase: N/A
Study type: Interventional

This study is a multicenter, randomized, double-blind, and sham-controlled trial using the identical protocol as the SNT to replicate the antidepressant efficacy of SNT for TRD. Patients will be recruited and randomly assigned (1:1 ratio) to receive active or sham groups from 5 hospitals in China. The interventions will last for 5 days and both groups will be followed up for 8 weeks on the same time schedules. During the intervention and at least the first 4 weeks of post-treatment, participants will keep a stable antidepressant regimen. The individualized SNT target in the left dorsolateral prefrontal cortex (DLPFC) will be generated from 30 minutes of resting-state functional MRI collected at baseline.

NCT ID: NCT06165900 Recruiting - Breast Cancer Clinical Trials

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

Start date: September 26, 2023
Phase: Phase 2
Study type: Interventional

This study was an open-label, multicenter, randomized study. It is planned to include 136 patients with stage II-III triple negative breast cancer. Eligible subjects will be randomized to receive either the experimental arm: adebrelimab plus stereotactic radiotherapy followed by adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin) or the control arm: adebrelimab plus nab-paclitaxel + carboplatin.

NCT ID: NCT06165874 Recruiting - Clinical trials for Non-small Cell Lung Cancer

[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer

Start date: March 12, 2023
Phase: N/A
Study type: Interventional

The aim of this study was to establish and optimize the imaging method of [68Ga]Ga-NOTA-RW102, as well as its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agent was evaluated in patients with non-small cell lung cancer

NCT ID: NCT06165718 Recruiting - Clinical trials for Pulmonary Artery Sarcoma

Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.

Start date: December 31, 2022
Phase:
Study type: Observational

This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.

NCT ID: NCT06165549 Recruiting - Clinical trials for Internet Gaming Disorder

Light Therapy for Internet Gaming Disorder

Start date: December 16, 2023
Phase: N/A
Study type: Interventional

This project aims to investigate (1) the efficacy of light therapy on internet gaming disorder (IGD); (2) the underlying neural mechanisms of such efficacy

NCT ID: NCT06165471 Recruiting - Nursing Education Clinical Trials

The Effectiveness of a Mobile Application for Teaching Clinical Nursing Skill at a Higher Education Institution in Chenzhou, China

Start date: December 15, 2023
Phase: N/A
Study type: Interventional

The general objective of this study is to validate a mobile application as a pedagogical tool compared to in-person nursing educational instruction for teaching clinical nursing skills and evaluate the effectiveness of clinical nursing skills for nursing students. The study design is a basic experimental study design, randomized control trial (RCT) design; the dependent variables measured in this study are skills, self-directed learning ability, online academic emotion, and satisfaction by using pre- and posttests; two groups are participating in this study; experimental and control group. The control group treatment is traditional face-to-face teaching, and the experimental group intervention is online and offline blended learning based on the Chaoxing app. The study process includes four steps: 1. To develop surgical nursing practical online courses using Chaoxing mobile app. 2. Perform the pre-test (basic sociological information, self-directed learning ability surveys ). 3. Nursing clinical practice skills education intervention. 4. Perform a posttest (assess practical skills, self-directed learning ability, online academic emotion, and satisfaction).

NCT ID: NCT06165380 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Start date: October 23, 2023
Phase: Phase 2
Study type: Interventional

The goal of this trial is to test the efficacy and safety of cardenilimab combined with chemotherapy in the conversion therapy of locally advanced unresectable esophageal squamous cell carcinoma. type of study: clinical trial